InsidersTradesSigma
WuXi Biologics (Cayman) Inc. Stock: price and management transactions · Hong Kong · HKEX
Follow the WuXi Biologics (Cayman) Inc. share price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares are quoted on HK HK, under the supervision of HKEX. Operating in the Health Care sector, WuXi Biologics (Cayman) Inc. has recorded 10 insider filings. Market capitalisation: €155bn. The latest transaction was filed on 23 June 2026 (Other). Among the most active insiders: Chen Zhisheng. Every trade is openly available.
10
Insider Decl.
0
Thresholds
·
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate WuXi Biologics (Cayman) Inc. Strong Buy (bullish), based on 22 analysts. Average price target: HK$46.75.
16Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 8,755 of 26,220 companies
59.8
score / 100
Value44
Quality76
FCF yld1.7%
Earn yld3.2%
EV/EBITDA17.5x
ROE12%
Gross mgn46%
Net mgn23%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 23 June 2026
Declarations10 total
378,080 sharesShareXHKGHKEX:DA20260622E00526
264,866 sharesShareXHKGHKEX:DA20260615E00437
29,677 sharesShareXHKGHKEX:DA20260615E00438
148,127 sharesShareXHKGHKEX:DA20260401E00525
16,724 sharesShareXHKGHKEX:DA20260401E00527
54,838 sharesShareXHKGHKEX:DA20260330E00500
Ideal exit: 20 Dec 2026 (T+270)
1,442,769 sharesShareXHKGHKEX:DA20260330E00499
Ideal exit: 20 Dec 2026 (T+270)
543,819 sharesShareXHKGHKEX:DA20260330E00501
Ideal exit: 20 Dec 2026 (T+270)
1,734 sharesShareXHKGHKEX:DA20260327E00406
6,713 sharesShareXHKGHKEX:DA20260326E00431
10 of 10 declarations
About WuXi Biologics (Cayman) Inc.
WuXi Biologics (Cayman) Inc. is a company specializing in biopharmaceutical services, providing development and manufacturing solutions for biological products. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.